CoChat

Effects of oral L-tyrosine administration of CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

To determine whether 1-tyrosine administration can enhance dopamine synthesis in humans as it does in rats, we measured levels of tyrosine and the major dopamine metabolite, homovanillic acid, in lumbar spinal fluids of 23 patients with Parkinson's disease before and during ingestion of 100 mg/kg/day of tyrosine. Nine patients took 100 mg/kg/day of probenecid in six divided doses for 24 hours prior to each spinal tap; 14 patients did not receive probenecid. L-tyrosine administration significantly increased CSF tyrosine levels in both groups of patients (p less than .01) and significantly increased homovanillic acid levels in the group of patients pretreated with probenecid (p less than .02). These data indicate that l-tyrosine administration can increase dopamine turnover in patients with disorders in which physicians wish to enhance dopaminergic neurotransmission.

Overview

Integrity signals

Registry

Crossref · 10.1016/0024-3205(82)90596-3

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Research works printed but not linked: 2

  1. Waakles, 1957, J. Lab. Clin. Med., 50, 733
  2. Melamed, 1980, 77, 4305

Cited by

See all 97

Metadata

Authors
Growdon, J. H., Melamed, E., Logue, M., Hefti, F., & Wurtman, R. J.
Affiliations
  • Tufts Medical Center (US)
  • Massachusetts Institute of Technology (US)
Venue
Life Sciences
Publisher
Elsevier BV
Published
1982-03
Volume
30
Issue
10
Pages
827-832
ISSN
0024-3205 (ISSN-L)
OpenAlex
W2075093684
Cited by
91
References
21
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 6 · 2013: 1 · 2012: 3
FWCI
6.90
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Life Sciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Parkinson Disease Association
  • Parkinson Vereniging
  • National Institutes of Health
  • U.S. Public Health Service
  • Fogarty International Center
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
tyrosine, Parkinson's disease, homovanillic acid, cerebrospinal fluid, dopamine synthesis, dopamine turnover, probenecid, lumbar puncture, dopamine signaling
MeSH terms
Administration, Oral, Chromatography, High Pressure Liquid, Homovanillic Acid, Humans, Hydroxyindoleacetic Acid, Parkinson Disease, Phenylacetates, Probenecid, Tyrosine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of oral L-tyrosine administration of CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. https://app.cochat.ai/papers/10.1016/0024-3205(82)90596-3
The paper
Growdon, J. H., Melamed, E., Logue, M., Hefti, F., & Wurtman, R. J. (1982). Effects of oral L-tyrosine administration of CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. Life Sciences. https://doi.org/10.1016/0024-3205(82)90596-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.